Socioeconomic factors associated with overweight and obesity: A case study among adult people of Bangladesh
AIUB Journal of Science and Engineering (AJSE) · 06.01.2020 · 16 (2)
DOI: 10.53799/ajse.v16i2.78 ↗Kurz gefasst
Fachartikel in der Zeitschrift AIUB Journal of Science and Engineering (AJSE), online erschienen am 06.01.2020. Verfasst von K. C. Bhuyan und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The analysis is done using the data collected from 785 adults of randomly selected families of 207 students of American International University - Bangladesh. The respondents are classified by levels of Body Mass Index (BMI). Among the respondents 86.4% are in the obese and overweight group and the prevalence of Non-communicable diseases (NCDs) and diabetes are higher among them. The important variables for the higher prevalence of overweight and obesity are residence, age, occupation, marital status and income. The obesity is more among the urban people. It is also more among aged persons, service and retired persons. The prevalence of diabetes is more among obese and overweight group of respondents.
Zitieren
APA
Bhuyan, K. C., & Ahmmed, M. M. (2020). Socioeconomic factors associated with overweight and obesity: A case study among adult people of Bangladesh. AIUB Journal of Science and Engineering (AJSE), 16(2). https://doi.org/10.53799/ajse.v16i2.78
Vancouver
Bhuyan KC, Ahmmed MM. Socioeconomic factors associated with overweight and obesity: A case study among adult people of Bangladesh. AIUB Journal of Science and Engineering (AJSE). 2020;16(2). doi:10.53799/ajse.v16i2.78
BibTeX
@article{Bhuyan2020,
author = {Bhuyan, K. C. and Ahmmed, Md. Mortuza},
title = {Socioeconomic factors associated with overweight and obesity: A case study among adult people of Bangladesh},
journal = {AIUB Journal of Science and Engineering (AJSE)},
year = {2020},
volume = {16},
number = {2},
doi = {10.53799/ajse.v16i2.78}
}
EUVIMED